Previous 10 | Next 10 |
Clinical-stage biotech, Sesen Bio (NASDAQ:SESN), is trading higher in the pre-market Thursday after the company updated on its resubmission plans for Vicineum, an investigational therapy for non-muscle invasive bladder cancer. Last year, U.S. Food and Drug Administration (FDA) declined to app...
Participated in productive CMC and Clinical Type A Meetings with the FDA in the fourth quarter Type C Meeting with the FDA planned for March 28, 2022 Strong balance sheet with $163M in cash and cash equivalents as of December 31, 2021 expected to fund current operating...
Minori Rosales, M.D., Ph.D. Brings Over 15 Years of Clinical Experience Stephanie Vigue to Support Company’s Mission with Broad Corporate Finance Expertise Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Put simply, 2021 was a great year to trade penny stocks under $1 per share — largely thanks to the Reddit meme stock phenomenon. Many may have believed elevated retail interest in day trading would cool with the re...
Intercontinental Exchange will add 138 securities to the ICE Biotechnology index and delete 26 as part of the annual reconstitution, effective prior to market open on December 20. Notable additions: Aurinia Pharmaceuticals (NASDAQ:AUPH), Anavex Life Sciences (NASDAQ:AVXL), Sesen Bio...
Cheap Penny Stocks To Buy On Webull Trading For Pennies Penny stocks are well-known for giving you the ability to make money quickly. By most definitions, I’m talking about stocks trading for less than $5 per share and typically have much smaller market caps than most compani...
The Nasdaq Biotechnology Index will have a new look on December 20, before the market opens when 129 securities will be added and 21 securities will be deleted as part of the annual reconstitution. Notable additions to the index: Viatris (NASDAQ:VTRS), NovoCure (NASDAQ:NVCR), Anavex Life Scie...
Sesen Bio (NASDAQ: SESN) wasn't a very healthy stock on Thursday. The biotech, which concentrates on developing treatments for cancer, saw its share price dive by nearly 18% on the day. This followed an update on the company's only pipeline drug. That drug is vicineum, for which...
Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...
Gainers: Inspira Technologies (NASDAQ:IINN) +103%, Ensysce Biosciences (NASDAQ:ENSC) +53%, Jasper Therapeutics (NASDAQ:JSPR) +24%, Ambrx Biopharma (NYSE:AMAM) +17%, iSpecimen (NASDAQ:ISPC) +15%. Losers: Reata Pharmaceuticals (NASDAQ:RETA)...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...